Summary for Dicyclomine


BreastfeedingPediatric
  • Trade Names: Antispaz; Bemote; Bentyl (Aptalis); Bentylol; Byclomine; Di-Spaz; Dibent; Formulex; Lomine; Merbentyl; Neoquess; Notensyl; OrTyl; Panakiron; Spasmoban; Spasmoject; Swityl
  • Indications: Irritable bowel syndrome
  • Class: Anticholinergic, Muscarinic antagonist
  • Half-life: initial: 1.8 hours; terminal: 9–10 hours
  • Clinically important, potentially hazardous interactions with:
    Antacids, Anticholinergics, Antiglaucoma agents, Arbutamine

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top